These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8356307)

  • 21. Ganciclovir with recombinant methionyl human granulocyte colony-stimulating factor for treatment of cytomegalovirus disease in AIDS patients.
    Jacobson MA; Stanley HD; Heard SE
    AIDS; 1992 May; 6(5):515-7. PubMed ID: 1377475
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.
    Manfredi R; Mastroianni A; Coronado O; Chiodo F
    J Chemother; 1996 Jun; 8(3):214-20. PubMed ID: 8808719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of recombinant human granulocyte colony-stimulating factor on protracted neutropenia in patients with acute myelogenous leukemia. (rG.CSF Clinical Study Group)].
    Kimura Y; Toyama K; Hirashima K; Okuma M; Saito H; Ohno R; Ikeda Y; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):589-96. PubMed ID: 7543954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rational therapy with G-CSF and GM-CSF].
    Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
    Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV disease-related neutropenia: an independent risk factor for severe infections.
    Hermans P
    AIDS; 1999; 13 Suppl 2():S11-7. PubMed ID: 10596676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current developments in the treatment of AIDS].
    Mulder JW
    Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1664-6. PubMed ID: 2477718
    [No Abstract]   [Full Text] [Related]  

  • 28. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
    AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of GM-CSF in patients with AIDS: a review of the literature.
    Ross SD; DiGeorge A; Connelly JE; Whiting GW; McDonnell N
    Pharmacotherapy; 1998; 18(6):1290-7. PubMed ID: 9855329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human granulocyte colony-stimulating factor (rHuG-CSF) for treatment of neutropenia in Shwachman syndrome.
    Ventura A; Dragovich D; Luxardo P; Zanazzo G
    Haematologica; 1995; 80(3):227-9. PubMed ID: 7545636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte macrophage colony stimulating factor (GM-CSF) in AIDS.
    Scadden DT
    Prog Clin Biol Res; 1990; 338():163-76. PubMed ID: 2189138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human granulocyte-macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. An open clinical trial.
    Piguet D; Chapuis B
    Acta Oncol; 1994; 33(6):639-43. PubMed ID: 7946441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
    Clumeck N; Wit SD; Hermans P; Franchioly P; Sommereijns B
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305
    [No Abstract]   [Full Text] [Related]  

  • 35. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
    Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
    J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
    van der Wouw PA; van Leeuwen R; van Oers RH; Lange JM; Danner SA
    Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution.
    Calderwood S; Doyle JJ; Hitzler JK; Saunders EF; Freedman MH
    Bone Marrow Transplant; 1996 Jul; 18(1):87-91. PubMed ID: 8832000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients.
    Hardy WD
    J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S22-8. PubMed ID: 1848618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
    J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.